Alyeska Investment Group’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-39,827
| Closed | -$1.03M | – | 518 |
|
2018
Q2 | $1.03M | Buy |
39,827
+1,274
| +3% | +$32.9K | 0.01% | 366 |
|
2018
Q1 | $921K | Buy |
+38,553
| New | +$921K | 0.01% | 361 |
|
2015
Q4 | – | Sell |
-98,380
| Closed | -$1.65M | – | 483 |
|
2015
Q3 | $1.65M | Buy |
98,380
+26,504
| +37% | +$444K | 0.02% | 340 |
|
2015
Q2 | $1.89M | Buy |
71,876
+1,163
| +2% | +$30.5K | 0.02% | 335 |
|
2015
Q1 | $1.24M | Buy |
70,713
+5,198
| +8% | +$90.9K | 0.02% | 392 |
|
2014
Q4 | $1.14M | Buy |
65,515
+43,537
| +198% | +$756K | 0.02% | 370 |
|
2014
Q3 | $409K | Sell |
21,978
-28,223
| -56% | -$525K | 0.01% | 343 |
|
2014
Q2 | $918K | Buy |
+50,201
| New | +$918K | 0.02% | 319 |
|